Mochi Health tirzepatide is compounded GLP-1 medication from a telehealth provider. Learn how pricing, dosing, pharmacy sourcing, and safety work.
Mochi Health tirzepatide is a compounded form of tirzepatide prescribed through Mochi Health, a US telehealth company that connects patients with licensed clinicians and partner compounding pharmacies. Tirzepatide is the active ingredient in the FDA-approved drugs Zepbound and Mounjaro, but compounded tirzepatide is not FDA-approved and is not a generic equivalent. Patients generally pay a monthly membership fee plus a separate medication fee, and a licensed provider must review your medical history before a prescription is written.
What Is Mochi Health Tirzepatide?
Mochi Health is a subscription telehealth service focused on weight management, available in most US states. Its tirzepatide product is an injectable liquid prepared by a licensed compounding pharmacy rather than a manufacturer's pen.
Tirzepatide works as a dual GIP and GLP-1 receptor agonist, which is a different mechanism from single-hormone GLP-1 drugs. In the SURMOUNT clinical trials of the brand-name product, adults with obesity lost roughly 15% to 21% of body weight over about 72 weeks, depending on dose.
Compounded drugs can legally be prepared when a licensed prescriber determines a patient needs a variation of an approved product, or under limited shortage-related allowances. Federal rules for compounding tirzepatide have tightened since the FDA resolved the shortage.
Mochi also offers mochi health semaglutide, which some patients choose because it targets only the GLP-1 receptor or because their provider prefers that starting point.
How Mochi Health's Program Works
The program is built around a membership, not a one-time purchase.
- Create an account and pay the membership fee. This unlocks access to the provider network.
- Complete a health intake. You report weight history, current medications, conditions, and any prior GLP-1 use.
- Meet a licensed provider. A clinician reviews your intake and decides whether tirzepatide is appropriate for you.
- The partner pharmacy fills the prescription. Medication ships to your address with syringes and written dosing instructions.
- Follow-up continues monthly. Doses are adjusted based on your response and side effects.
Mochi Health does not manufacture medication; it prescribes through licensed compounding pharmacies. You can ask for the pharmacy's name, license number, and state board status before you start.
Mochi Health Tirzepatide Cost and Provider Comparison
Pricing in this category changes often, so treat any figure as a snapshot rather than a guarantee.
| Cost component | Typical range | What it covers |
|---|---|---|
| Monthly membership | About $70–$90 | Provider visits, messaging, dose adjustments |
| Compounded tirzepatide | Roughly $180–$400 per month | Vial or prefilled syringe, supplies, shipping |
| Brand-name tirzepatide | $350–$1,000+ per month | Zepbound or Mounjaro pens and vials |
Other telehealth programs use similar models. Programs such as brello health tirzepatide often advertise flat monthly pricing, while belle health tirzepatide uses a subscription structure. Compare both on pharmacy sourcing, cancellation terms, and whether provider visits are included.
Insurance rarely covers compounded tirzepatide. Brand-name tirzepatide is more likely to be covered for type 2 diabetes than for weight loss, and coverage varies widely by plan.
Before you commit, ask these questions:
- Which pharmacy compounds the medication, and is it a 503A or 503B facility?
- What concentration is printed on the label, and how do units convert to milligrams?
- Is the membership fee refundable if you cancel partway through a month?
- Who do you contact after hours if you develop severe side effects?
Compounded vs. Brand-Name Tirzepatide
| Feature | Compounded (Mochi and similar) | Brand-name (Zepbound, Mounjaro) |
|---|---|---|
| FDA approval | Not FDA-approved | FDA-approved |
| Active ingredient | Tirzepatide | Tirzepatide |
| Dosing format | Vial or syringe; measured in units | Single-dose pen or vial |
| Strength consistency | Varies by pharmacy and lot | Standardized |
| Typical monthly cost | Lower | Higher |
Compounded tirzepatide is not the same product as Zepbound or Mounjaro, even though the active ingredient is identical. Concentration differences between pharmacies are one reason dose instructions should never be copied from one vial to another.
Is Compounded Tirzepatide Safe? Dosing and Side Effects
Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality the way brand-name products are. Lack of FDA review does not automatically make compounded tirzepatide unsafe, but it shifts the quality burden onto the pharmacy and the prescriber.
Regulatory status has also shifted. The FDA removed tirzepatide from its shortage list in late 2024, which restricted large-scale compounding, and enforcement timelines have continued to move amid litigation. Availability from any telehealth provider can change quickly as a result.
Common side effects of tirzepatide include nausea, vomiting, diarrhea, constipation, fatigue, and injection-site reactions. Serious risks listed on the brand labeling include pancreatitis, gallbladder disease, gastroparesis, dehydration from persistent vomiting, and a boxed warning about thyroid C-cell tumors observed in rodents.
Some people search for how much bac water to reconstitute 20mg tirzepatide, but DIY reconstitution of lyophilized powder is a different practice from what Mochi and similar clinics ship. Compounded tirzepatide from a licensed pharmacy arrives already in liquid form with a stated concentration, and patients should follow only the units their own provider and pharmacy specify.
Talk with a licensed healthcare professional before starting, stopping, or combining any weight loss medication.
Other Options: Cagrilintide and Emerging Peptides
Interest in next-generation compounds keeps growing, and several are frequently measured against tirzepatide. In any cagrilintide vs tirzepatide comparison, the key difference is approval status: cagrilintide is an investigational amylin analog that is not FDA-approved for any use, while tirzepatide is approved in brand form.
Cagrilintide is being studied mainly in combination with semaglutide, not as a like-for-like replacement for tirzepatide, and combination products are not available by prescription today. Combining unapproved peptides with a prescribed GLP-1 adds unknown risk, because side effects, interactions, and proper dosing have not been studied in humans for most of these pairings, and sourcing is unregulated.
Frequently Asked Questions
Is Mochi Health tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved for any use, and Mochi Health's product is a compounded medication rather than the brand drug. Zepbound and Mounjaro are the FDA-approved tirzepatide products, and both are manufactured by Eli Lilly.
How much does Mochi Health charge for tirzepatide?
Mochi Health charges a monthly membership fee, commonly around $70 to $90, plus a separate medication fee that generally runs a few hundred dollars per month depending on dose. The total usually lands well below the list price of brand-name tirzepatide. Confirm current pricing directly with the company, because it changes frequently.
Can I get tirzepatide from Mochi Health without insurance?
Yes. Mochi Health's compounded tirzepatide is sold as a self-pay subscription, so insurance is not required. You still need a provider evaluation and approval before any prescription is filled and shipped.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.